American Academy of Family Physicians

Printer-friendly version

Share this on AAFP Connection

Share this page

Bush Signs Legislation Giving FDA More Oversight

By James Arvantes

The FDA will have new authority to regulate medications and medical devices that are already on the market under a bill recently signed by President Bush.

The Food and Drug Administration Amendments Act of 2007, H.R. 3580, (at the Library of Congress' THOMAS Web site type "HR 3580" in the search bar after selecting "Bill Number") gives the FDA the authority to take various actions to help determine if approved drugs or medical devices pose health risks, including by providing on-line access to studies on the drugs or medical devices.

"When studies are done, that information will be made available on a Web site so the public and scientists can have access to that information," said Diana Zuckerman, Ph.D., president of the National Research Center for Women and Families, explaining some provisions of the bill.

Under the new law, the FDA has the ability to limit distribution of a product and order label changes on products that pose a risk. In addition, the agency will have more resources and authority to monitor medications and medical devices that already are on the market.

The measure was passed as part of legislation to reauthorize the Prescription Drug User Fee Act, or PDUFA, and the Medical Drug User Fee Modernization Act, or MDUFMA. Companies that make medical products pay the FDA user fees under PDUFA and MDUFMA as part of the approval process for drugs and medical devices respectively. The acts were set to expire on Sept. 30 before Bush signed H.R. 3580 into law on Sept. 27.

In recent years, a few blockbuster drugs and widely used implants have caused life-threatening and life-ending illnesses in some patients, prompting the enhancement of the FDA's regulatory powers under H.R. 3580, which is intended to "close some of these gaps in safety," said Zuckerman.

Some consumer advocates are convinced that the FDA has gotten too close to the pharmaceutical and medical device industries in recent years, weakening the agency's role as a regulator and causing the agency to "disregard patient protections," to approve drugs faster, Zuckerman said in an interview with AAFP News Now. Zuckerman and other consumer advocates are disappointed that the new law does not give the FDA more regulatory authority, such as the power to preview all direct-to-consumer ads to make sure they are not misleading.

Rich Buckley, vice president of federal government affairs for AstraZeneca, a pharmaceutical company, disagrees that the law does not give the FDA enough regulatory authority. The law represents a "bi-partisan compromise" that "will give the (FDA) additional resources and tools to do its job," says Buckley.

"That is a benefit to the pharmaceutical industry, but more importantly it is a benefit to the millions of patients and families who rely on the agency to do its job," he said.

Buckley strongly disagrees with "the notion that the FDA is rubber-stamping drug applications."

"To the contrary, our experience with the agency is they are very diligent with their work, that they take their job very seriously, and when they see a problem, they don't hesitate to act," he said.

Share this on AAFP Connection

Search AAFP News Now

 

Government & Medicine

Fee-For-Service Is Here to Stay for Now, Says Policy Expert

Legislators Air Differing Views on Health Care Reform

OTC Prescription Provision Creates Burden

House Bill Would Reform Medicare Payment

Pharmacists Prescribing? Absolutely Not, Says AAFP

AAFP, Others Asks CMS to Re-evaluate Penalty Timelines

Proposed CMS Rule on Overpayment Creates Difficulties

Nurse Education Demo Must Focus on Primary Care, Says AAFP

FP Advocacy Focus of Recent Visit to Capitol Hill

Funding Needed for Family Medicine Programs

Permanently Adopting Primary Care Pay Hike Could Save Billions

Study Highlights Role of CHCs in Health Care System

Ensuring Access to GME Is Focus of Message on Capitol Hill

Congress Passes Payment Patch, Fails to Repeal SGR

AAFP Continues to Press for SGR Repeal on Capitol Hill

Groups Demand That Congress Fix the SGR

PCMH Is Answer to Medicare Payment Problems

Physician Groups Unite to Call for SGR Repeal

Threatened Medicare Payment Cuts Cause Chaos for FPs

AAFP, Medical Organizations Push for SGR Repeal

Focus of Conference Call is Shared Savings, Advance Payment

AAFP Renews Push for SGR Fix

FPs Can Expect Slight Changes in Medicare Pay for 2012

HHS Approach to Essential Health Benefits Falls Flat

CMS Delays Implementation of 'Sunshine Act'

Congress Works Out Temporary Solution to SGR Cut

Community-based Residencies Would Benefit From House Bill

GME Funding to Remain Level in 2012

House Rejects Measure to Block Medicare Pay Cut

House Addresses Medicare Payment Cut

AAFP Backs Tavenner as New CMS Administrator

Supercommittee Fails to Address SGR

Overcoming Scarce Resources to Enact Health Care Reform

Medicare Payment: Value Is as Important as Volume

AAFP President-elect Makes Return Visit to Capitol Hill

Insurance Exchanges, CO-OPs Might Provide Opportunity for FPs

AAFP Members Speak Out on Title VII Funding

Campaign Addresses Need for Medicare Payment Reform

AAFP Continues to Press Congress for Payment Solution

AAFP Leaders Take On Washington

Campaign Focuses on GME Outreach

'Family Medicine Matters,' AAFP Members Tell Congress

AAFP Outlines Suggested Changes for CO-OP Program

Groups Call on Supercommittee to Address Medical Liability Reform

Grassroots Efforts to Repeal SGR Continue

Bill Linking Mandatory Education to Prescribing Not Needed

Blended Payment Model Gives Boost to Primary Care Services

AAFP Joins AMA, Other Groups in Calling for SGR Repeal

Eliminating SGR May Come With High Price

Tobacco Oversight Must Include Cigars, Say AAFP, Other Groups

AAFP Rallies Congress of Delegates on Medicare Payment

AMA Task Force Focuses on Fixing the SGR

2012 Physician Fee Schedule Needs Work, Says AAFP

New Task Force Takes Steps to Better Value Primary Care

Deficit-reduction Plan Must Eliminate SGR, Says AAFP

Physicians File Lawsuit Over RUC, CMS Relationship

Policy Brief Explains HHS Insurance Exchange Plans

Deficit-reduction Plan Falls Short, Says AAFP President

YouTube Video Designed to Encourage SGR Repeal